Real-World Study of Tildrakizumab Survival in Psoriasis: Impact of Arthritis, Hypertension, and Prior Biologic Use

Real-World Study of Tildrakizumab Survival in Psoriasis: Impact of Arthritis, Hypertension, and Prior Biologic Use

In routine clinical settings, identifying the factors that influence the persistence of biologic therapies is crucial for tailoring psoriasis management to individual patient profiles. This study aimed to evaluate the real-world drug survival of tildrakizumab in patients diagnosed with plaque psoria...

Full description

Saved in:
Bibliographic Details
Main Authors: Raquel Santos-Juanes Galache, Sebastian Reyes García, Jimena Carrero Martín, Álvaro Nuñez Domínguez, Marta López Pando, Irene Álvarez Losada, Irene de la Fuente Villaverde, Ana Lozano-Blazquez, Esther Salgueiro, Javier Bordallo, Jorge Santos-Juanes, Cristina Galache Osuna
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Life
Subjects:
tildrakizumab
Anti-IL23
real world
Online Access:https://www.mdpi.com/2075-1729/15/5/789
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2075-1729/15/5/789

Similar Items